Mathai Mammen, Janssen global head of R&D (Rob Tannenbaum, Endpoints News)
Covid-19 roundup: Study shows J&J's shot is much less effective against Delta variant; Novartis open to manufacturing other coronavirus vaccines — report
As the Delta variant rapidly spreads across the US — accounting for 83% of the country’s cases, CDC director Rochelle Walensky said yesterday — a new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
